Patent ID: 8580500

Claim:
A method of diagnosing a subject having lung cancer, comprising: a.) obtaining a test sample from a subject having, or suspected of having lung cancer, wherein the sample is extracted from lung tissue; b.) measuring, by hybridization assay, the level of at least three miR gene products in the test sample; c.) comparing the level of at least one miR-21 gene product, one miR-210 gene product, and one miR-205 gene product in the test sample from the subject to a corresponding control level of at least one miR-21 gene product, one miR-210 gene product, and one miR-205 gene product; and d.) diagnosing the subject as having lung cancer, if the level of at least one miR-21 gene product, one miR-210 gene product, and one miR-205 gene product in the test sample from the subject is greater than the corresponding control level of miR-21 gene product, miR-210 gene product, and miR-205 gene product; wherein an increase in the levels of the miR-21 gene product, the miR-210 gene product and the miR-205 gene product, is indicative of the subject having lung cancer.